---
title: "12 Health Care Stocks Moving In Friday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293808187.md"
description: "During Friday's after-market session, several healthcare stocks experienced significant volatility. Gainers included China SXT Pharmaceuticals (up 41.1%), iTonic Holdings (+8.67%), and ALPS Group (+7.25%). Conversely, losers featured Akanda (-12.2%), Valion Bio (-9.1%), and Quoin Pharmaceuticals (-6.31%). The report highlights specific price movements and market capitalizations for these listed companies."
datetime: "2026-07-24T21:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293808187.md)
  - [en](https://longbridge.com/en/news/293808187.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293808187.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's After-Market Session

### Gainers

-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Friday's after-market session. The market value of their outstanding shares is at $12.7 million.
-   **iTonic Holdings** (NASDAQ:ITOC) shares increased by 8.67% to $0.29. The company's market cap stands at $4.7 million.
-   **ALPS Group** (NASDAQ:ALPS) stock increased by 7.25% to $0.5. The company's market cap stands at $78.4 million.
-   **Medicus Pharma** (NASDAQ:MDCX) shares rose 6.64% to $0.39. The market value of their outstanding shares is at $21.7 million.
-   **Soligenix** (NASDAQ:SNGX) shares increased by 6.26% to $0.39. The market value of their outstanding shares is at $5.4 million.
-   **Scinai Immunotherapeutics** (NASDAQ:SCNI) stock increased by 5.56% to $0.24. The company's market cap stands at $1.2 million.

### Losers

-   **Akanda** (NASDAQ:AKAN) shares declined by 12.2% to $6.79 during Friday's after-market session. The market value of their outstanding shares is at $4.3 million.
-   **Valion Bio** (NASDAQ:VBIO) shares decreased by 9.1% to $0.27.
-   **Quoin Pharmaceuticals** (NASDAQ:QNRX) shares fell 6.31% to $4.01. The company's market cap stands at $8.7 million.
-   **Adial Pharmaceuticals** (NASDAQ:ADIL) stock fell 5.8% to $2.53. The company's market cap stands at $5.8 million.
-   **NextCure** (NASDAQ:NXTC) shares fell 5.19% to $4.02. The market value of their outstanding shares is at $17.0 million.
-   **Cardio Diagnostics Hldgs** (NASDAQ:CDIO) shares fell 5.17% to $1.47. The company's market cap stands at $4.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ITOC.US](https://longbridge.com/en/quote/ITOC.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [QNRX.US](https://longbridge.com/en/quote/QNRX.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [ALPS.US](https://longbridge.com/en/quote/ALPS.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [SNGX.US](https://longbridge.com/en/quote/SNGX.US.md)
- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)
- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md)
- [CDIO.US](https://longbridge.com/en/quote/CDIO.US.md)
- [ALPWF.US](https://longbridge.com/en/quote/ALPWF.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)
- [74907L409.US](https://longbridge.com/en/quote/74907L409.US.md)
- [CDIOW.US](https://longbridge.com/en/quote/CDIOW.US.md)

## Related News & Research

- [The Rare Earth Mirage: The Midstream Bet Hiding in Plain Sight (NASDAQ: EMAT)](https://longbridge.com/en/news/296940044.md)
- [FibroBiologics Regains Compliance with Nasdaq Trading Rules | FBLG Stock News](https://longbridge.com/en/news/297048305.md)
- [Greenland Mines (NASDAQ: GRML) Initial Assessment Values Sarfartoq at Up to $2.05B Pre-Tax NPV](https://longbridge.com/en/news/296932902.md)
- [Evolution Metals Is Making the Magnet Every Defense Prime Still Can't Source (NASDAQ: EMAT)](https://longbridge.com/en/news/297068269.md)
- [After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)](https://longbridge.com/en/news/296918567.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**